BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2010
View Archived Issues
Sanofi-aventis discovers new casein kinase I inhibitors
Read More
Lorcaserin reduces body weight in phase III BLOOM/BLOSSOM trials
Read More
Belatacept superior to ciclosporin in renal transplant recipients
Read More
AstraZeneca synthesizes new ATR kinase inhibitors as oncolytics
Read More
Nhwa Pharma describes new serotonin 5-HT2A antagonists
Read More
Sigma-Tau retinoid derivatives may be active against metastatic cancer
Read More
Betagenon claims new AMPK activators
Read More
ONO-5334 has beneficial effects on bone in postmenopausal women
Read More
Elevated GGT in serum is a risk factor for breast cancer
Read More
Linifanib/mFOLFOX6 combination shows promise in metastatic colorectal cancer
Read More
LCT reports additional phase II data on DiabeCell in type 1 diabetes
Read More
HGS and Lonza form commercial manufacturing agreement for Benlysta
Read More
Hologic resubmits Gestiva NDA for prevention of preterm birth
Read More
Presidio Pharma completes phase Ia trial of HCV inhibitor PPI-461
Read More
Silence Therapeutics and AstraZeneca extend siRNA development collaboration
Read More
Aestus and Eisai to develop new therapeutics for psychiatric disorders
Read More
Innocoll submits SPA for phase III trial of Cogenzia for foot ulcer infections in diabetes
Read More
Trevena secures financing for TRV-120027 in acute heart failure
Read More
Peregrine begins second phase IIb trial of bavituximab in NSCLC
Read More
ChemGenex to submit new NDA for Omapro as third-line CML therapy
Read More
Cubist's phase II safety trial of Cubicin in prosthetic joint infections meets objectives
Read More
ISTA begins phase I/II trial of bepotastine besilate nasal spray for seasonal allergic rhinitis
Read More
BTG issues annual general meeting and interim management statement
Read More
Nabi completes enrollment in first of two phase III NicVAX trials
Read More
FDA clears Starpharma's phase II trial of VivaGel in bacterial vaginosis
Read More